SCHEMBL22693240

SCHEMBL22693240

Cc1ccc(C(=O)N2CCN(c3ccccc3S(N)(=O)=O)CC2)c(C)c1NC1CCN(c2cc#ccc2C#N)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 7/20 0.54
RPTOR Q8N122 7/20 0.54
MLST8 Q9BVC4 7/20 0.54
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA9 Q16790 2/20 0.36
EED O75530 1/20 0.34
LMNA P02545 3/20 0.34
GAA P10253 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GLA P06280 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
GFER P55789 1/20 0.33
P2RY12 Q9H244 1/20 0.33
MAPT P10636 2/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20133575 0.92 MTOR (0.62) MTORRPTORMLST8CA12CA1
SCHEMBL20133747 0.83 MTOR (0.72) MTORRPTORMLST8CA12CA1
SCHEMBL21360301 0.81 MTOR (0.78) MTORRPTORMLST8CA12CA1
SCHEMBL20133763 0.81 MTOR (0.80) MTORRPTORMLST8CA12CA1
SCHEMBL22693196 0.80 MTOR (0.54) MTORRPTORMLST8CA12CA1
SCHEMBL20129696 0.79 MTOR (0.59) MTORRPTORMLST8CA12CA1
SCHEMBL20133549 0.78 MTOR (0.64) MTORRPTORMLST8CA12CA1
SCHEMBL20133561 0.78 MTOR (0.52) MTORRPTORMLST8L3MBTL1TSHR
SCHEMBL21360359 0.78 MTOR (0.71) MTORRPTORMLST8CA12CA1
SCHEMBL22693241 0.77 MTOR (0.49) MTORRPTORMLST8CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2020-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.